World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
25719
World Ranking
986
National Ranking
537

Medicine

D-Index
95
Citations
26698
World Ranking
10204
National Ranking
5246

Marc Peters-Golden publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marc Peters-Golden sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 353 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marc Peters-Golden D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Peters-Golden sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marc Peters-Golden is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. Within these broad areas, their work focuses on subfields such as Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research, and Biochemistry.

A significant portion of their research concentrates on topics including Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Immune cells in cancer, Extracellular vesicles in disease, Eicosanoids and Hypertension Pharmacology, DNA Repair Mechanisms, Influenza Virus Research Studies, and Immune Response and Inflammation.

They have contributed to several journals and publication venues with multiple works. Frequent venues for their publications include bioRxiv (Cold Spring Harbor Laboratory), JCI Insight, The FASEB Journal, The Journal of Immunology, and Frontiers in Pharmacology.

Recent notable papers authored by or associated with their research include:

  • Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?, 2022, Frontiers in Pharmacology
  • Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions, 2021, JCI Insight
  • GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress, 2023, Cancer Discovery
  • Resident alveolar macrophage-derived vesicular SOCS3 dampens allergic airway inflammation, 2020, The FASEB Journal
  • Age-induced prostaglandin E2 impairs mitochondrial fitness and increases mortality to influenza infection, 2022, Nature Communications

Marc Peters-Golden has collaborated extensively with several frequent co-authors including Jennifer M. Speth, Loka R. Penke, S.M. Fortier, Natalie Walker, and Costas A. Lyssiotis.

Best Publications

  • Mechanisms of disease: Leukotrienes

    Marc Peters-Golden;William R. Henderson

  • Influence of body mass index on the response to asthma controller agents

    M. Peters-Golden;A. Swern;S. S. Bird;C. M. Hustad

  • Cyclic AMP: master regulator of innate immune cell function.

    Carlos H. Serezani;Megan N. Ballinger;David M. Aronoff;Marc Peters-Golden

  • Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

    Jerome Wilborn;Leslie J. Crofford;Marie D. Burdick;Steven L. Kunkel

  • Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.

    Stephen T. Holgate;Marc Peters-Golden;Reynold A. Panettieri;William R. Henderson

  • Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP

    David M. Aronoff;Claudio Canetti;Marc Peters-Golden

  • Leukotrienes: Underappreciated Mediators of Innate Immune Responses

    Marc Peters-Golden;Claudio Canetti;Peter Mancuso;Michael J. Coffey

  • Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia

    Peter Mancuso;Andrew Gottschalk;Susan M. Phare;Marc Peters-Golden

  • Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts

    Vibha N. Lama;Lisa Smith;Linda Badri;Andrew Flint

  • Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2

    Thomas G. Brock;Robert W. McNish;Marc Peters-Golden

  • Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells.

    Dirk O. Stichtenoth;Staffan Thorén;Huimin Bian;Marc Peters-Golden

  • Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.

    Jill E. Kolodsick;Marc Peters-Golden;José Larios;Galen B. Toews

  • Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities.

    Marc B. Bailie;Theodore J. Standiford;Lauri L. Laichalk;Michael J. Coffey

  • The alveolar macrophage: the forgotten cell in asthma.

    Marc Peters-Golden

  • 5-lipoxygenase and FLAP.

    M. Peters-Golden;T.G. Brock

  • Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1.

    David M. Aronoff;Claudio Canetti;Carlos H. Serezani;Carlos H. Serezani;Ming Luo

  • Pathologic changes in the lungs of oxygen-adapted rats: a morphometric analysis.

    Crapo Jd;Peters-Golden M;Marsh-Salin J;Shelburne Js

  • Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.

    Wen Tian;Xinguo Jiang;Rasa Tamosiuniene;Yon K. Sung

  • Cysteinyl leukotrienes: multi‐functional mediators in allergic rhinitis

    M. Peters-Golden;M. M. Gleason;A. Togias

  • Lung Resident Mesenchymal Stem Cells Isolated from Human Lung Allografts Inhibit T Cell Proliferation via a Soluble Mediator

    Lamis Jarvinen;Linda Badri;Scott Wettlaufer;Takashi Ohtsuka

  • 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation.

    John W. Woods;Michael J. Coffey;Thomas G. Brock;Irwin I. Singer

  • Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. Discussion

    Stephen T. Holgate;Marc Peters-Golden;Reynold A. Panettieri;William R. Henderson

Frequent Co-Authors

David M. Aronoff
David M. Aronoff Indiana University
Bethany B. Moore
Bethany B. Moore University of Michigan–Ann Arbor
Galen B. Toews
Galen B. Toews University of Michigan–Ann Arbor
Eric S. White
Eric S. White University of Michigan–Ann Arbor
Theodore J. Standiford
Theodore J. Standiford University of Michigan–Ann Arbor
Richard Simon
Richard Simon University of Michigan–Ann Arbor
Jeffrey L. Curtis
Jeffrey L. Curtis University of Michigan–Ann Arbor
Cory M. Hogaboam
Cory M. Hogaboam Cedars-Sinai Medical Center
James J. Moon
James J. Moon University of Michigan–Ann Arbor
David J. Pinsky
David J. Pinsky University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often opens doors to diverse healthcare roles requiring advanced education and specialized training. For those interested in blending immunological knowledge with nursing, programs like the cheapest pmhnp programs online provide accessible pathways into psychiatric mental health nursing, specializing in patient care that involves immune system-related mental health disorders.

If you’re considering advanced nursing roles, a Doctorate in Nursing offers competitive opportunities. Understanding the doctorate in nursing salary can help you assess the financial benefits linked with this level of education, informing your long-term career decisions in fields intertwined with immunology and patient care.

For nurses looking to expand their clinical expertise, a fnp to acute care np bridge program can be a strategic choice. This transition equips family nurse practitioners with skills to manage acute conditions, many of which have immunological implications, enhancing career versatility.

Additionally, accelerated nurse practitioner program options offer expedited routes to certification, enabling swift entry into specialized healthcare roles that intersect with immunology. These programs are ideal for professionals seeking to fast-track their careers in this dynamic field.

Best Scientists Citing Marc Peters-Golden

Trending Scientists

Recently Published Articles